New computational model can predict breast cancer survival

April 17, 2013

Columbia Engineering researchers, led by Dimitris Anastassiou, Charles Batchelor Professor in Electrical Engineering and member of the Columbia Initiative in Systems Biology, have developed a new computational model that is highly predictive of breast cancer survival. The team, who won the Sage Bionetworks / DREAM Breast Cancer Prognosis Challenge for this work, published their results—"Development of a Prognostic Model for Breast Cancer Survival in an Open Challenge Environment"—in the April 17 issue of Science Translational Medicine.

In earlier work, Anastassiou and his team had identified what he calls "attractor metagenes," gene signatures that are present in nearly identical form in many . Working with his PhD students Wei-Yi Cheng and Tai-Hsien Ou Yang, he took these signatures and tested them in the Sage Bionetworks/DREAM Challenge, a crowd-sourced effort for accurate breast cancer prognosis using molecular and clinical data. The team developed a prognostic model that showed that these signatures of cancer, when properly combined, were strong predictors for breast .

"These signatures manifest themselves in specific genes that are turned on together in the tissues of some patients in many different cancer types," explains Anastassiou. "And if these general cancer signatures are useful in , as we proved in this Challenge, then why not in other as well? I think that the most significant—and exciting—implication of our work is the hope that these signatures can be used for improved diagnostic, prognostic, and eventually, therapeutic products, applicable to multiple cancers."

Currently there are already widely used biomarker products that look at specific genes in biopsies of , so that doctors can decide if particular treatments are appropriate. "Some of these genes are related to those in our signatures," he says, "so it's worth finding out if replacing such with our precise 'pan-cancer' signatures will improve the accuracy of these products."

Anastassiou, who works in , an emergent interdisciplinary field that focuses on interactions within biological systems, hopes to collaborate with medical researchers studying the biological mechanisms behind these cancer signatures. He thinks of these signatures as "bioinformatic hallmarks of cancer," a term first coined by Jessica Kandel, R. Peter Altman Professor of Surgery and Pediatrics in Columbia's Institute for Cancer Genetics, with whom he collaborates.

"The hallmarks of cancer," he explains, "are unifying biological capabilities present in all cancers, as described in some seminal papers. We think that we have now reached the point where systems biology can also identify such hallmarks."

"We are thrilled that Anastassiou's innovative metagenes approach won the Challenge and is getting the visibility it rightly deserves," says Stephen H. Friend, president and co-founder, Sage Bionetworks. "Anastassiou's team demonstrated gumption and a thoughtful understanding of what was needed to develop a 'generalizable' model that achieved the top CCI score against the newly generated Challenge validation data set."

Anastassiou and his team found the Sage Bionetworks/DREAM Challenge a very productive way to focus on a specific research task. He said that the Challenge provided a vibrant research environment where numerous participants were openly submitting their models and had access to others' models as they were developed. The teams were also encouraged to incorporate the other models into their own. Three hundred fifty-four participants from more than 35 countries registered for the Challenge and submitted more than 1700 models.

The study was funded by the University's allocation for inventor's research—patents from what Anastassiou calls his "previous lifetime," when he was doing research on a totally different topic: digital television. His patents are now used in the international standards for all forms of DVDs including Blu-ray HDTV discs and digital television broadcasting.

Explore further: New method identifies genes that can predict prognoses of cancer patients

Related Stories

New method identifies genes that can predict prognoses of cancer patients

January 25, 2013
In recent years, it has been thought that select sets of genes might reveal cancer patients' prognoses. However, a study published last year examining breast cancer cases found that most of these "prognostic signatures" were ...

Genetic predictor of breast cancer response to chemotherapy

May 10, 2012
Chemotherapy is a major first line defense against breast cancer. However a patient's response is often variable and unpredictable. A study published in BioMed Central's open access journal BMC Medical Genomics shows that ...

Scientists identify genetic signatures for aggressive form of prostate cancer

October 8, 2012
Scientists have discovered two separate genetic 'signatures' for prostate cancer that appear to be able to predict the severity of the disease, leading to hopes that in future, accuracy of prognosis and treatment of the disease ...

Computer model helps researchers hunt out cancer-causing mutational signatures in the genome

January 11, 2013
(Medical Xpress)—Researchers from the Wellcome Trust Sanger Institute's cancer genome project have developed a computer model to identify the fingerprints of DNA-damaging processes that drive cancer development. Armed with ...

Recommended for you

Vitamin C may encourage blood cancer stem cells to die

August 17, 2017
Vitamin C may "tell" faulty stem cells in the bone marrow to mature and die normally, instead of multiplying to cause blood cancers. This is the finding of a study led by researchers from Perlmutter Cancer Center at NYU Langone ...

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.